Market Overview:
The global sepsis diagnostics market is expected to exhibit a CAGR of 9.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Sepsis is a medical condition caused due to the body’s response to fight infections that are based on contamination with bacteria, viruses, or fungi. In this condition, the immune system releases several chemicals into the bloodstream that trigger hyper inflammation and the formation of blood clots in the body. Sepsis may result in multiple organ failures, irregular breathing, low blood pressure, neurological dysfunction, faster heart rate, etc. The diagnostic procedures for sepsis primarily include molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, etc. These diagnostic technologies are widely adopted across hospitals, pathology and reference laboratories, academic research institutes, etc.
Global Sepsis Diagnostics Market Trends and Drivers:
The growing prevalence of hospital-acquired infections (HAIs) that causes sepsis, particularly among the geriatric population, infants, and patients suffering from chronic illness, is currently driving the demand for sepsis diagnostics. Furthermore, the rising incidences of numerous infectious diseases caused due to antibiotic-resistant bacteria, including gram-positive bacteria and gram-negative bacilli, are also propelling the need for sepsis diagnostics. Additionally, the expanding healthcare sector along with the increasing penetration of advanced data analytics tools is further catalyzing the sepsis diagnostics market growth. These data analytics tools have enabled the integration of multiple test results from diverse platforms, thereby providing real-time data access and accurate disease diagnosis. Moreover, several technological advancements have led to the emergence of novel immunological and molecular biomarkers that enable the early detection of sepsis. In line with this, the rising investments in extensive R&D activities that include new blood culture approaches for identifying and treating chronic infections are also driving the market for sepsis diagnostics.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global sepsis diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on diagnosis, product, mode of testing, technology, pathogen and end user.
Breakup by Diagnosis:
- Automated Diagnostics
- Conventional Diagnostics
Breakup by Product:
- Instruments
- Assay Kits and Reagents
- Blood Culture Media
- Software
Breakup by Mode of Testing:
- Laboratory Tests
- Point-of-Care Tests
Breakup by Technology:
- Molecular Diagnostics
- Immunoassays
- Biomarkers
- Flow Cytometry
- Microfluidics
- Blood Culture
Breakup by Pathogen:
- Bacterial Sepsis
- Gram-Positive Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
- Viral Sepsis
- Fungal Sepsis
- Others
Breakup by End User:
- Diagnostic Clinics
- Hospitals
- Research Laboratories
Breakup by Region:
- North America
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
- Asia Pacific
- China
- India
- Japan
- Australia
- Singapore
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Becton, Dickinson and Company (BD), biomerieux SA, Bruker Corporation, EKF Diagnostics Holding Plc, Epic Systems Corporation, Luminex Corporation, Roche Holding AG, Sysmex Corporation, and T2 Biosystems Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Million |
| Segment Coverage |
Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, Australia, Singapore, Brazil, Mexico, Argentina, Saudi Arabia, United Arab Emirates, South Africa |
| Companies Covered |
Abbott Laboratories, Becton, Dickinson and Company (BD), biomerieux SA, Bruker Corporation, EKF Diagnostics Holding Plc, Epic Systems Corporation, Luminex Corporation, Roche Holding AG, Sysmex Corporation, and T2 Biosystems Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global sepsis diagnostics market performed so far and how will it perform in the coming years?
- What is the impact of COVID-19 on the global sepsis diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the diagnosis?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the mode of testing?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the pathogen?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the global sepsis diagnostics market and who are the key players?
- What is the degree of competition in the market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Sepsis Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Diagnosis
6.1 Automated Diagnostics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Conventional Diagnostics
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product
7.1 Instruments
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Assay Kits and Reagents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Blood Culture Media
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Software
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Mode of Testing
8.1 Laboratory Tests
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Point-of-Care Tests
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Technology
9.1 Molecular Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Immunoassays
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Biomarkers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Flow Cytometry
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Microfluidics
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Blood Culture
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by Pathogen
10.1 Bacterial Sepsis
10.1.1 Gram-Positive Bacterial Sepsis
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Gram-Negative Bacterial Sepsis
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Viral Sepsis
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Fungal Sepsis
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by End User
11.1 Diagnostic Clinics
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Hospitals
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Research Laboratories
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Europe
12.2.1 Germany
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 France
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 United Kingdom
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 Italy
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Spain
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Others
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.3 Asia Pacific
12.3.1 China
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 India
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 Japan
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Australia
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Singapore
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Others
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Argentina
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.4.4 Others
12.4.4.1 Market Trends
12.4.4.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Saudi Arabia
12.5.1.1 Market Trends
12.5.1.2 Market Forecast
12.5.2 United Arab Emirates
12.5.2.1 Market Trends
12.5.2.2 Market Forecast
12.5.3 South Africa
12.5.3.1 Market Trends
12.5.3.2 Market Forecast
12.5.4 Others
12.5.4.1 Market Trends
12.5.4.2 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Becton, Dickinson and Company (BD)
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 biomerieux SA
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Bruker Corporation
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 EKF Diagnostics Holding Plc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Epic Systems Corporation
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 Luminex Corporation
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Roche Holding AG
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Sysmex Corporation
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 T2 Biosystems Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
List of Figures
Figure 1: Global: Sepsis Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Sepsis Diagnostics Market: Breakup by Diagnosis (in %), 2021
Figure 4: Global: Sepsis Diagnostics Market: Breakup by Product (in %), 2021
Figure 5: Global: Sepsis Diagnostics Market: Breakup by Mode of Testing (in %), 2021
Figure 6: Global: Sepsis Diagnostics Market: Breakup by Technology (in %), 2021
Figure 7: Global: Sepsis Diagnostics Market: Breakup by Pathogen (in %), 2021
Figure 8: Global: Sepsis Diagnostics Market: Breakup by End User (in %), 2021
Figure 9: Global: Sepsis Diagnostics Market: Breakup by Region (in %), 2021
Figure 10: Global: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Sepsis Diagnostics (Automated Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Sepsis Diagnostics (Automated Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Sepsis Diagnostics (Conventional Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Sepsis Diagnostics (Conventional Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Sepsis Diagnostics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Sepsis Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Sepsis Diagnostics (Assay Kits and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Sepsis Diagnostics (Assay Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Sepsis Diagnostics (Blood Culture Media) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Sepsis Diagnostics (Blood Culture Media) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Sepsis Diagnostics (Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Sepsis Diagnostics (Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Sepsis Diagnostics (Laboratory Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Sepsis Diagnostics (Laboratory Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Sepsis Diagnostics (Point-of-Care Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Sepsis Diagnostics (Point-of-Care Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Sepsis Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Sepsis Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Sepsis Diagnostics (Immunoassays) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Sepsis Diagnostics (Immunoassays) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Sepsis Diagnostics (Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Sepsis Diagnostics (Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Sepsis Diagnostics (Flow Cytometry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Sepsis Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Sepsis Diagnostics (Microfluidics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Sepsis Diagnostics (Microfluidics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Sepsis Diagnostics (Blood Culture) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Sepsis Diagnostics (Blood Culture) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Sepsis Diagnostics (Bacterial Sepsis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Sepsis Diagnostics (Bacterial Sepsis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Sepsis Diagnostics (Gram-Positive Bacterial Sepsis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Sepsis Diagnostics (Gram-Positive Bacterial Sepsis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Sepsis Diagnostics (Gram-Negative Bacterial Sepsis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Sepsis Diagnostics (Gram-Negative Bacterial Sepsis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Sepsis Diagnostics (Viral Sepsis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Sepsis Diagnostics (Viral Sepsis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Sepsis Diagnostics (Fungal Sepsis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Sepsis Diagnostics (Fungal Sepsis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Sepsis Diagnostics (Other Pathogens) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Sepsis Diagnostics (Other Pathogens) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Sepsis Diagnostics (Diagnostic Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Sepsis Diagnostics (Diagnostic Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Global: Sepsis Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Global: Sepsis Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Global: Sepsis Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Global: Sepsis Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: North America: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: North America: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United States: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United States: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Canada: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Canada: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Asia Pacific: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Asia Pacific: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: China: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: China: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: India: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: India: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Japan: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Japan: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Australia: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Australia: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Singapore: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Singapore: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Others: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Others: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Latin America: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Latin America: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Brazil: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Brazil: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Mexico: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Mexico: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Argentina: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Argentina: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Others: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 100: Others: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 101: Middle East and Africa: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 102: Middle East and Africa: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 103: Saudi Arabia: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 104: Saudi Arabia: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 105: United Arab Emirates: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 106: United Arab Emirates: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 107: South Africa: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 108: South Africa: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 109: Others: Sepsis Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 110: Others: Sepsis Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 111: Global: Sepsis Diagnostics Industry: SWOT Analysis
Figure 112: Global: Sepsis Diagnostics Industry: Value Chain Analysis
Figure 113: Global: Sepsis Diagnostics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Sepsis Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Sepsis Diagnostics Market Forecast: Breakup by Diagnosis (in Million US$), 2022-2027
Table 3: Global: Sepsis Diagnostics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: Sepsis Diagnostics Market Forecast: Breakup by Mode of Testing (in Million US$), 2022-2027
Table 5: Global: Sepsis Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 6: Global: Sepsis Diagnostics Market Forecast: Breakup by Pathogen (in Million US$), 2022-2027
Table 7: Global: Sepsis Diagnostics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 8: Global: Sepsis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Sepsis Diagnostics Market: Competitive Structure
Table 10: Global: Sepsis Diagnostics Market: Key Players